Sponsored Research According to Therapeutic Area in 2020
Top therapeutic areas (excluding bioequivalence studies) of sponsored research conducted in 2020 are in oncology, infectious disease, and endocrinology
Classification of Interventional Studies in Malaysia, 2020
Phase III form the largest type of sponsored interventional research, followed by Bioequivalence/ Bioavailability studies and Phase II studies.
Top Sponsors with the Most Sponsored Research in 2019
Novartis, Merck Sharpe & Dohme and Sunmed Research Fund (from Sunway Medical Centre) were the top 3 sponsors in 2019.
Top CROs with the Most Sponsored Research in 2019
IQVIA, Info Kinetics & PPD were the top 3 contract research organisations in 2019. Bioequivalence studies made up for most of the sponsored research conducted by Info Kinetics, a locally based CRO located in Penang.
Clinical Research in Malaysia: 2019 Achievements
Ranked #8
In patient recruitment among IQVIA Global Prime Sites, 2019
83%
Average recruitment rate in studies managed by CRM
136%
Increase in full feasibility studies that came through CRM between 2013 and 2019
Top 7 Globally
Malaysia ranked as best start-up timeline in SEA &
84%
Of Sponsors / CROs & investigators rated “Good” & and above on CRM’s Study Coordinators Services
Certified
CRM is ISO 9001:2015 Certified
6 times
Growth of Sponsors utilizing CRM’s feasibility service (2014 – 2019)
59 days
CTA review timeline reduced from 59 days to 13 days between 2012 and 2017